1. Home
  2. AVDL vs MEG Comparison

AVDL vs MEG Comparison

Compare AVDL & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • MEG
  • Stock Information
  • Founded
  • AVDL 2015
  • MEG 2012
  • Country
  • AVDL Ireland
  • MEG United States
  • Employees
  • AVDL N/A
  • MEG N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • MEG Professional Services
  • Sector
  • AVDL Health Care
  • MEG Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • MEG Nasdaq
  • Market Cap
  • AVDL 861.4M
  • MEG 764.0M
  • IPO Year
  • AVDL 1996
  • MEG 2020
  • Fundamental
  • Price
  • AVDL $10.83
  • MEG $22.02
  • Analyst Decision
  • AVDL Strong Buy
  • MEG Buy
  • Analyst Count
  • AVDL 7
  • MEG 5
  • Target Price
  • AVDL $18.71
  • MEG $31.80
  • AVG Volume (30 Days)
  • AVDL 1.6M
  • MEG 351.6K
  • Earning Date
  • AVDL 08-07-2025
  • MEG 08-05-2025
  • Dividend Yield
  • AVDL N/A
  • MEG N/A
  • EPS Growth
  • AVDL N/A
  • MEG N/A
  • EPS
  • AVDL N/A
  • MEG N/A
  • Revenue
  • AVDL $194,450,000.00
  • MEG $718,904,000.00
  • Revenue This Year
  • AVDL $56.86
  • MEG $10.49
  • Revenue Next Year
  • AVDL $30.45
  • MEG $7.06
  • P/E Ratio
  • AVDL N/A
  • MEG N/A
  • Revenue Growth
  • AVDL 252.64
  • MEG 10.92
  • 52 Week Low
  • AVDL $6.38
  • MEG $10.51
  • 52 Week High
  • AVDL $17.30
  • MEG $40.84
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 72.02
  • MEG 50.71
  • Support Level
  • AVDL $8.74
  • MEG $21.93
  • Resistance Level
  • AVDL $9.56
  • MEG $23.23
  • Average True Range (ATR)
  • AVDL 0.41
  • MEG 0.89
  • MACD
  • AVDL 0.18
  • MEG -0.21
  • Stochastic Oscillator
  • AVDL 89.88
  • MEG 23.82

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

Share on Social Networks: